BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa
Introduction Malaria continues to be a major cause of morbidity and mortality in sub-Saharan Africa (SSA) without effective interventions. Bacillus Calmette-Guérin (BCG) vaccine possesses protective non-specific effects, which extend beyond protection against tuberculosis. This study explores whethe...
Saved in:
| Main Authors: | Peter Aaby, Christine S Benn, Mike LT Berendsen, Sjors WL van Gijzel, Jeroen Smits, Quirijn de Mast, Mihai G Netea, Andre JAM van der Ven |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/6/e001862.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau
by: Peter Aaby, et al.
Published: (2020-09-01) -
Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study
by: Peter Aaby, et al.
Published: (2020-02-01) -
Can earlier BCG vaccination reduce early infant mortality? Study protocol for a cluster randomised trial in Guinea-Bissau
by: Peter Aaby, et al.
Published: (2019-09-01) -
BCG-Induced Trained Immunity in Healthy Individuals: The Effect of Plasma Muramyl Dipeptide Concentrations
by: Vera P. Mourits, et al.
Published: (2020-01-01) -
Intravesical BCG in patients with non-muscle invasive bladder cancer induces trained immunity and decreases respiratory infections
by: J Alfred Witjes, et al.
Published: (2023-01-01)